franz x. vollenweider
Project Participant Franz X. Vollenweider, PhD
​
MD, FMH Psy., Dipl.Chem.tech.
Professor, Chief Psychiatrist & Director, Center for Psychiatric Research, Psych. Hospital, University of Zürich
​
List of relevant publications and Patents within the last five years
Total publications 1990-2018: 110 PubMed listed with 2 Highly Cited Publication in Field. Sum of the times cited: 6087 (WEB of Science, March 2018) - H-Index: 47
Krähenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX (2015) Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Biol Psychiatry 78: 572-581
Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX (2016) Effects of serotonin 2A/1A receptor stimulation on social exclusion processing, Proc Natl Acad Sci U S A 113: 5119-5124
Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, Liechti ME, Seifritz E, Vollenweider FX (2017) The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Curr Biol 27:451-457
Pokorny T, Preller, K.H Kometer M, Dziobek, I, Vollenweider FX (2017), Effect of the preferential 5-HT2A/1A agonist psilocybin on empathy and moral decision making, In. J Neuropsychopharmacol 20:747-757.
Preller KH, Schilbach L, Pokorny T, Flemming J, Seifritz E, Vollenweider FX (2018) Role of the 5-HT2A receptor in self- and other-initiated social interaction in LSD-induced states - a pharmacological fMRI study, J Neurosci 38:3603-3611
.jpg)
EDUCATION
1982-1986 Doctoral Thesis, Inst. of Toxicology of ETH and Univ. ZH, Schwerzenbach
1987-1989 Postdoctoral Fellow, Brain Research Institute, Univ. ZH, Zürich
1989-1991 Residency in Psychiatry, Psychiatric University Hospital Zürich, Research Dept.
1991-1993 Research Assistant, PET Center Paul Scherrer Institute (PSI-ETH), Villigen
1994 Residency in Internal Medicine, Dept of Internal Medicine, PUK, Zürich,
1995 Senior Resident, PUK, Zürich
1996- Head of Research Group “Neuropsychopharmacology and Brain”, PUK ZH
2000 Habilitation, University of Zürich: The Neurobiology of Model Psychoses
2002-2007 Research Coordinator, Clinic for Affective Disorders and General Psychiatry Zürich
2007- Associate Professor of Psychiatry, University of Zürich
2012- Co-Director Center for Psychiatric Research, DPPP, Psychiatry Hospital, Univ. ZH
2016- Chief Psychiatrist (Chefarzt), DPPP, Psychiatry Hospital, Univ. ZH
awards
1990 Twinning Grant 1990, Award of the Swiss Society for Biol. Psychiatry, Switzerland
1997 Heffter Institute Award 1997 (USA) for outstanding clinical research, USA
2000 Götz Prize of the University of Zürich, Switzerland,
2000 NARSAD Independent Invest. Award, USA
2002 BAP Prize 2002, British Association for Psychopharmacology (BAP), London
2004 NARSAD Independent Invest. Award, USA
2008 Achievement Award, Alliance for Psychiatric Disorders, New York, USA
2015 Fetzer Institute AWARD, USA